ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,890.10
0.00%
S&P ASX All Technology
3,489.20
0.00%
Brent Oil
69.665
0.91%
US Dollar vs AUD
1.58758
-0.32%
Bitcoin
82,645.55
5.32%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Benitec Biopharma Limited (BNTC)

  7. Benitec Biopharma Limited (BNTC) News

BNTC

Benitec Biopharma (BNTC)

Benitec Biopharma Limited
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNTC
DateTimeSourceHeadlineSymbolCompany
15/02/202500:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
14/02/202523:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
04/01/202509:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
31/12/202422:34Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:BNTCBenitec Biopharma Limited
14/12/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
12/12/202410:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/12/202409:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
12/12/202409:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNTCBenitec Biopharma Limited
11/12/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
07/12/202409:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
15/11/202408:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
15/11/202408:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
15/11/202408:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BNTCBenitec Biopharma Limited
15/11/202408:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
13/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNTCBenitec Biopharma Limited
02/11/202408:04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNTCBenitec Biopharma Limited
24/10/202400:23Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
23/10/202408:24Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNTCBenitec Biopharma Limited
15/10/202423:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
15/10/202421:08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
12/10/202408:13Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNTCBenitec Biopharma Limited
12/10/202407:53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
12/10/202407:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
09/10/202407:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
02/10/202406:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNTCBenitec Biopharma Limited
27/09/202406:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
27/09/202406:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BNTCBenitec Biopharma Limited
30/07/202406:28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
20/07/202406:59Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BNTCBenitec Biopharma Limited
16/07/202407:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNTCBenitec Biopharma Limited
 Showing the most relevant articles for your search:NASDAQ:BNTC

Your Recent History

BIT
WSGC27
SG
COIN
POLUSD
POL (ex-MATIC)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads